Výsledky vyhledávání - "Ruben Tijssen"

Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial

Autor: Jan J. Piek, Karin Arkenbout, Jan G.P. Tijssen, Ruben Tijssen, Robin P. Kraak, José P.S. Henriques, Hector M. Garcia-Garcia, Sjoerd H. Hofma, Mick P.L. Renkens, Robbert J. de Winter, Laura S.M. Kerkmeijer, René J. van der Schaaf, Joanna J. Wykrzykowska, Auke P.J.D. Weevers

Publikováno v: Eurointervention, 17(16), 1340-1347. EUROPA EDITION
EuroIntervention
EuroIntervention, 17(16), 1340-1347. EuroPCR

BACKGROUND: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1 and 3 years - the period of active scaffold bioresorption. Data on the performance of the Absorb BVS in daily clinical practice beyond this time poin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda3d38c9a499b5b0bee2f4431870f93
https://doi.org/10.4244/eij-d-21-00419

Zobrazit plný text záznamu

The role of ADAMTS13 in acute myocardial infarction

Autor: Matthijs F. Jansen, Jeroen A.M. Beliën, Elise S. Eerenberg, Bert-Jan H. van den Born, Paul F. Teunissen, Ruben Tijssen, Niels van Royen, Maurits R. Hollander, Marcel Levi, Mohamed F.A. Aly, Hans W.M. Niessen, Peter M. van de Ven, Otto Kamp, Pieter W. Kamphuisen, Joost C. M. Meijers

Publikováno v: Cardiovascular Research, 111(3), 194-203. Oxford University Press
Eerenberg, E S, Teunissen, P F A, van den Born, B-J, Meijers, J C M, Hollander, M R, Jansen, M, Tijssen, R, Belien, J A M, van de Ven, P M, Aly, M F, Kamp, O, Niessen, H W, Kamphuisen, P W, Levi, M & van Royen, N 2016, ' The role of ADAMTS13 in acute myocardial infarction : cause or consequence? ', Cardiovascular Research, vol. 111, no. 3, pp. 194-203 . https://doi.org/10.1093/cvr/cvw097
Cardiovascular Research
Cardiovascular research, 111(3), 194-203. Oxford University Press

AIMS: ADAMTS13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13, is a metalloprotease that cleaves von Willebrand factor (VWF). There is considerable evidence that VWF levels increase and ADAMTS13 levels decrease in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2afb085d728fed1d8806613875c08a7
https://doi.org/10.1093/cvr/cvw097

Zobrazit plný text záznamu

Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction

Autor: Martijn W. Smulders, Inés García-Lunar, Raquel P. Amier, Borja Ibanez, Niels van Royen, Rodrigo Fernández-Jiménez, Sebastiaan C.A.M. Bekkers, Ruben Tijssen, Robin Nijveldt, Gonzalo Pizarro, Paul F. Teunissen, Teresa Bastante, Aernout M. Beek, Peter M. van de Ven

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6, 8, pp. e005651-e005651
Journal of the American Heart Association, 6(8):e005651. Wiley-Blackwell
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Amier, R P, Tijssen, R Y G, Teunissen, P F A, Fernández-Jiménez, R, Pizarro, G, García-Lunar, I, Bastante, T, van de Ven, P M, Beek, A M, Smulders, M W, Bekkers, S C A M, van Royen, N, Ibanez, B & Nijveldt, R 2017, ' Predictors of intramyocardial hemorrhage after reperfused ST-segment elevation myocardial infarction ', Journal of the American Heart Association, vol. 6, no. 8, e005651 . https://doi.org/10.1161/JAHA.117.005651
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6, e005651-e005651

Background Findings from recent studies show that microvascular injury consists of microvascular destruction and intramyocardial hemorrhage ( IMH ). Patients with ST‐segment elevation myocardial infarction ( STEMI ) with IMH show poorer prognoses t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75963b9a05dcd4f5cb1399ed8ac2bad4
https://doi.org/10.1161/JAHA.117.005651

Zobrazit plný text záznamu

TCT-796 A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial

Autor: Jan Tijssen, Karin Arkenbout, Jan J. Piek, Ruben Tijssen, Sjoerd H. Hofma, Karel T. Koch, Robin P. Kraak, René J. van der Schaaf, Laura S.M. Kerkmeijer, Auke P.J.D. Weevers, Marije M. Vis, Joanna J. Wykrzykowska, Robert de Winter, Deborah Kalkman, Jose Ps. Henriques, Jan Baan

Publikováno v: Journal of the American College of Cardiology. 72:B316-B317

Females are underrepresented in clinical trials evaluating new stent technologies. This sub-analysis sought to assess sex-specific outcomes after bioresorbable scaffold implantation. The AIDA trial was an investigator-initiated, non-inferiority, all-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8eb28f93064b944a91762c4180ca8858
https://doi.org/10.1016/j.jacc.2018.08.2030

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání